Manufacturer announced that it has submitted a Pre-Market Approval supplement to the U.S. Food and Drug Administration for its Visian ICL, a toric implantable collamer lens designed to treat both nearsightedness and astigmatism.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Nutrients included in the BioTears oral formulation have been suggested in clinical studies to systemically control the inflammatory process associated with dry eye syndrome (tear film dysfunction).
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Eyeonics, the developer and manufacturer of the Crystalens, the first and only FDA approved accommodating intraocular lens, today announced the presentation of several independent clinical studies of the Crystalens and its accommodative function at the 2006 American Society of…
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Lasik and other doctors have agreed to donate 100% of their fees for one day to raise more than $200,000 for Colorado youth center.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Virgina ophthalmologist invited to S. Korea and China to lecture to their ophthalmology societies about clinical experience, outcomes, and recommendations with Epi-Lasik.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Company announced the introduction of its Precision Series™ intraocular lens implants (IOLs) for treating patients with cataracts.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Among the many symptoms endured by menopausal and peri-menopausal women is dry eye, a condition that, if left untreated, may lead to increased risk of infection or visual impairment. However, a recent survey…
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
Two popular laser-assisted surgeries to correct nearsighted vision - Lasik and PRK - are equally effective at restoring 20/20 vision six months to a year after the procedure, concludes a review of recent studies.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
The Medical Advisory Panel of Addition Technology, Inc., awarded the best paper at the 10th Intacs Roundtable to Luis Cadarso, M.D., of Vigo, Spain
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org
I am writing this letter because we find ourselves in a position where the safety of one of our products, ReNu with MoistureLoc, manufactured at our United States plant, is in question. And that most certainly raises…
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org